Search

everythinglearnresearchcommunity

for

Search:↓

Black hairy tongue can be an early sign of graft-versus-host disease after stem cell transplants.

Skin grafts from related donors significantly healed chronic wounds in patients with a severe skin condition over a year.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Using an anti-ICAM-1 antibody with rapamycin improves hair transplant survival in monkeys.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

People with allergies or high eosinophil levels have a higher chance of severe hair loss from alopecia areata, and sudden hair loss can indicate chronic graft-versus-host disease.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

A five-month-old boy with Omenn syndrome successfully recovered after a stem cell transplant with reduced intensity conditioning.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

New scaffold materials help heal severe skin wounds and improve skin regeneration.

Some children who had stem cell transplants developed permanent hair loss, especially when treated with a drug called busulphan.

Topical treatments and skin care improve transplant-related atopic dermatitis in children.

A woman's sudden hair loss three years after a bone marrow transplant was a sign of chronic graft-versus-host disease but improved with treatment.

A 65-year-old man developed a serious skin cancer linked to a drug he was taking for a fungal infection after a bone marrow transplant.

Skin issues from chronic graft-versus-host disease greatly affect daily life, needing teamwork between blood and skin doctors.

Artificial skin grafts face immune rejection, but stem cells may improve future designs.

cGVHD often severely affects the skin, causing rapid aging and other issues.

Frozen-thawed fibroblast sheets enhance wound healing and hair growth in mice.

Graft-versus-host disease occurs when donor immune cells attack the recipient's body, causing skin, gut, and liver damage.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.

CMV infection increases the risk of GvHD after bone marrow transplants.

Busulfan/cyclophosphamide and total bone irradiation are equally effective for AML transplants.

Amotosalen-treated donor T-cells can prevent late CMV infection after bone marrow transplants.

FTY720 helps transplanted fat survive better by reducing immune rejection and improving blood vessel growth.

Skin problems are common after stem cell transplants, and early treatment by dermatologists can improve patient outcomes.

Platelet concentrates are useful for tissue repair in medicine and dentistry, with L-PRF showing promising results in various treatments.

Female donor to male recipient sex mismatch and positive ACA-IgG are key risk factors for vitiligo and alopecia areata in chronic GvHD patients.

Older age is the main risk factor for hemorrhagic cystitis after stem cell transplants.